Preconditioning the myocardium: From cellular physiology to clinical cardiology

Physiological Reviews

Volumn 83, Issue 4, 2003, Pages 1113-1151

  Yellon, Derek M ^a   Downey, James M ^b  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; BRADYKININ; CELL SURFACE RECEPTOR; GLIBENCLAMIDE; GLIMEPIRIDE; HEPTANOL; METHYLXANTHINE; NICORANDIL; NORADRENALIN; OPIATE AGONIST; ORAL ANTIDIABETIC AGENT; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE;

CELL FUNCTION; DRUG DESIGN; ELECTROCARDIOGRAM; HEART INFARCTION; HEART MITOCHONDRION; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; RECEPTOR OCCUPANCY; REVIEW; SIGNAL TRANSDUCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0141751749     PISSN: 00319333     EISSN: None     Source Type: Journal    
DOI: 10.1152/physrev.00009.2003     Document Type: Review

References (418)

1. Abete P, Ferrara N, Cacciatore F, Madrid A, Bianco S, Calabrese C, Napoli C, Scognamiglio P, Bollella O, Cioppa A, Longobardi G, and Rengo F. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol 30: 947-954, 1997.
2. Abete P, Ferrara N, Cioppa A, Ferrara P, Bianco S, Cacciatore F, Longobardi G, and Rengo F. Preconditioning does not prevent postischemic dysfunction in aging heart. Am J Cardiol 27: 1777-1786, 1996.
3. Abete P, Napoli C, and Rengo F. Loss of cardioprotective effects of preconditioning angina in elderly but not in adult patients. Am J Cardiol 88: 721, 2002.
4. Airaksinen KE and Huikuri HV. Antiarrhythmic effect of repeated coronary occlusion during balloon angioplasty. J Am Coll Cardiol 29: 1035, 1997.
5. Alkhulaifi AM, Pugsley WB, and Yellon DM. The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection. Cardioscience 4: 163-169, 1993.
6. Allo SN, Bagby L, and Schaffer SW. Taurine depletion, a novel mechanism for cardioprotection from regional ischemia. Am J Physiol Heart Circ Physiol 273: H1956-H1961, 1997.
7. Alonzo A, Darbenzio R, Parham C, and Grover G. Effects of intracoronary cromakalim on postischaemic contractile function and action potential duration. Cardiovasc Res 26: 1046-1053, 1992.
8. Andreotti F and Pasceri V. Ischemic preconditioning. Lancet 348: 204, 1996.
9. Andreotti F, Pasceri V, Hackett DR, Davies GJ, Haider AW, and Maseri A. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 334: 7-12, 1996.
10. Anversa P, Cheng W, Liu Y, Leri A, Redaelli G, and Kajstura J. Apoptosis and myocardial infarction. Basic Res Cardiol 93 Suppl 3: 8-12, 1998.
11. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, Handa S, and Ogawa S. Preinfarction angina as a major predictor of left ventricular function and long term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 26: 319-327, 1995.
12. Armstrong S, Downey JM, and Ganote CE. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. Cardiovasc Res 28: 72-77, 1994.
13. Armstrong SC, Delacey M, and Ganote CE. Phosphorylation state of hsp27 and p38 MAPK during preconditioning and protein phosphatase inhibitor protection of rabbit cardiomyocytes. J Mol Cell Cardiol 31: 555-567, 1999.
14. Armstrong SC and Ganote CE. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes. J Mol Cell Cardiol 24: 869-884, 1992.
15. Arstall MA, Zhao YZ, Hornberger L, Kennedy SP, Buchholtz RA, Osathanondh R, and Kelly RA. Human ventricular myocytes in vitro exhibit early and delayed preconditioning responses to simulated ischemia. J Mol Cell Cardiol 30: 210-214, 1998.
16. 6-(3-iodobenzyl) adenosine-5′-N-methyluronamide protects against myocardial stunning and infarction without hemodynamic changes in conscious rabbits. Circ Res 80: 800-809, 1997.
17. Baines CP, Goto M, and Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 29: 207-216, 1997.
18. ATP channels and actin cytoskeleton. Am J Physiol Heart Circ Physiol 276: H1361-H1368, 1999.
19. Baines CP, Pass JM, and Ping P. Protein kinases and kinase modulated effectors in the late phase of ischemic preconditioning. Basic Res Cardiol 96: 207-218, 2001.
20. Baines CP, Wang L, Cohen MV, and Downey JM. Protein tyrosine kinase is downstream of protein kinase C for ischemic preconditioning's anti-infarct effect in the rabbit heart. J Mol Cell Cardiol 30: 383-392, 1998.
21. Baines CP, Zhang J, Wang GW, Zheng YT, Xiu JX, Cardwell EM, Bolli R, and Ping P. Mitochondrial PKCepsilon and MAPK form signaling modules in the murine heart: enhanced mitochondrial PKCepsilon-MAPK interactions and differential MAPK activation in PKCepsilon-induced cardioprotection. Circ Res 90: 390-397, 2002.
22. 1-adrenergic mechanism. Circ Res 73: 656-670, 1993.
23. Barancik M, Htun P, and Schaper W. Okadaic acid and anisomycin are protective and stimulate the SAPK/JNK pathway. J Cardiovasc Pharmacol 34: 182-190, 1999.
24. Barancik M, Htun P, Strohm C, Kilian S, and Schaper W. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death. J Cardiovasc Pharmacol 35: 474-483, 2000.
25. Barbosa V, Sievers RE, Zaugg CE, and Wolf CL. Preconditioning ischemia time determines the degree of glycogen depletion and infarct size reduction in rat hearts. Am Heart J 131: 224-230, 1996.
26. Baxter GF, Goma FM, and Yellon DM. Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium. Br J Pharmacol 115: 222-224, 1995.
27. Baxter GF, Goma FM, and Yellon DM. Characterisation of the infarct-limiting effect of delayed preconditioning: time course and dose-dependency studies in rabbit myocardium. Basic Res Cardiol 92: 159-167, 1997.
28. Baxter GF, Marber MS, Patel VC, and Yellon DM. Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation 90: 2993-3000, 1994.
29. Baxter GF, Mocanu MM, and Yellon DM. Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo. J Mol Cell Cardiol 29: 1967-1975, 1997.
30. Baxter GF and Yellon DM. Time course of delayed myocardial protection after transient A1 receptor activation in the rabbit. J Cardiovasc Pharmacol 29: 631-638, 1997.
31. 1 receptor activation. J Mol Cell Cardiol 31: 981-989, 1999.
32. Becker LB, Vanden Hoek TL, Shao Z-H, Li C-Q, and Schumacker PT. Generation of superoxide in cardiomyocytes during ischemia before reperfusion. Am J Physiol Heart Circ Physiol 277: H2240-H2246, 1999.
33. Behar S, Reicher-Reiss H, and Allmader E. The prognostic significance of angina pectoris preceding the occurrence of a first myocardial infarction in 4166 consecutive hospilized patients. Am Heart J 123: 1481-1486, 1992.
34. Behrends M, Schulz R, Post H, Alexandrov A, Belosjorow S, Michel MC, and Heusch G. Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs. Am J Physiol Heart Circ Physiol 279: H1111-H1119, 2000.
35. Belhomme D, Peynet J, Louzy M, Launay J-M, Kitakaze M, and Menasche P. Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100: II-340-II-344, 1999.
36. Bell RM, Smith CC, and Yellon DM. Nitric oxide as a mediator of delayed pharmacological (A1 receptor triggered) preconditioning: is eNOS masquerading as iNOS? Cardiovasc Res 53: 405-413, 2002.
37. Bell RM and Yellon DM. The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovasc Res 52: 274-280, 2001.
38. Bell SP, Sack MN, Patel A, Opie LH, and Yellon DM. Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol 36: 2296-2302, 2000.
39. Belosjorow S, Schulz R, Dorge H, Schade FU, and Heusch G. Endotoxin and ischemic preconditioning: TNF-alpha concentration and myocardial infarct development in rabbits. Am JPhysiol Heart Circ Physiol 277: H2470-H2475, 1999.
40. Bernado NL, D'Angelo M, Okubo S, Joy A, and Kukreja RC. Delayed ischemic preconditioning is mediated by opening of ATP-sensitive potassium channels in rabbit heart. Am J Physiol Heart Circ Physiol 276: H1323-H1330, 1999.
41. Billinger M, Fleisch M, Eberli FR, Garachemani A, Meier B, and Seiler C. Is the development of myocardial tolerance to repeated ischemia in humans due to preconditioning or to collateral recruitment? J Am Coll Cardiol 33: 1027-1035, 1999.
42. Birincioglu M, Yang X-M, Critz SD, Cohen MV, and Downey JM. S-T segment voltage during sequential coronary occlusions is an unreliable marker of preconditioning. Am J Physiol Heart Circ Physiol 277: H2435-H2441, 1999.
43. Bluhm WF, Martin JL, Mestril R, and Dillmann WH. Specific heat shock proteins protect microtubules during simulated ischemia in cardiac myocytes. Am J Physiol Heart Circ Physiol 275: H2243-H2249, 1998.
44. Bogoyevitch M, Gillespie-Brown J, Ketterman A, Fuller S, Ben-Levy R, Ashworth A, Marshall C, and Sugden P. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. Circ Res 79: 162-173, 1996.
45. Bolli R. The late phase of preconditioning. Circ Res 87: 972-983, 2000.
46. Bolli R, Bhatti ZA, Tang X-L, Qiu Y, Zhang Q, Guo Y, and Jadoon AK. Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ Res 81: 42-52, 1997.
47. Bolli R, Dawn B, Tang X-L, Qiu Y, Ping P, Xuan Y-T, Jones WK, Takano H, Guo Y, and Zhang J. The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol 93: 325-338, 1998.
48. Bolli R, Manchikalapudi S, Tang X-L, Takano H, Qiu Y, Guo Y, Zhang Q, and Jadoon AK. The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Circ Res 81: 1094-1107, 1997.
49. Bolli R and Marbán E. Molecular and cellular mechanisms of myocardial stunning. Physiol Rev 79: 609-634, 1999.
50. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens 11: 43-48, 2002.
51. Borsch-Haubold AG, Pasquet S, and Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059: SB 203580 also inhibits thromboxane synthase. J Biol Chem 273: 28766-28772, 1998.
52. Brown JM, Terada LS, Grosso MA, Whitmann GJ, Velasco SE, Patt A, Harken AH, and Repine JE. Xanthine oxidase produces hydrogen peroxide which contributes to reperfusion injury of ischemic, isolated, perfused rat hearts. J Clin Invest 81: 1297-1301, 1988.
53. Burckhartt B, Yang X-M, Tsuchida A, Mullane KM, Downey JM, and Cohen MV. Acadesine extends the window of protection afforded by ischaemic preconditioning in conscious rabbits. Cardiovasc Res 29: 653-657, 1995.
54. Burns PG, Krukenkamp IB, Caldarone CA, Gaudette GR, Bukhari EA, and Levitsky S. Does cardiopulmonary bypass alone elicit myoprotective preconditioning. Circulation 92: 447-451, 1995.
55. Camitta MG, Gabel SA, Chulada P, Bradbury JA, Langenbach R, Zeldin DC, and Murphy E. Cyclooxygenase-1 and -2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. Circulation 104: 2453-2458, 2001.
56. Carmitta MGW, Gabel SA, Chulada P, Bradbury JA, Langenbach R, Zeldin DC, and Murphy E. Cylooxygenase 1 and 2 knockout mice demonstrate increased cardiac ischemia/reperfusion injury but are protected by acute preconditioning. Circulation 104: 2453-2458, 2001.
57. Carr CS, Grover GJ, Pugsley WB, and Yellon DM. Comparison of the protective effects of a highly selective ATP-sensitive potassium channel opener and ischaemic preconditioning in iolsated human atrial muscle. Cardiovasc Drugs Ther 11: 473-478, 1997.
58. 3 receptors in protection of isolated human atrial muscle against simulated ischaemia. Cardiovasc Res 36: 52-59, 1997.
59. Carr CS and Yellon DM. A highly selective ATP-dependent potassium channel opener mimics ischaemic preconditioning protection in isolated human atrium. Med Sci Res 24: 651-654, 1996.
60. Carr CS and Yellon DM. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle. Basic Res Cardiol 92: 252-260, 1997.
61. ATP channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. Cardiovasc Res 51: 691-700, 2001.
62. Cave AC and Hearse DJ. Ischaemic preconditioning and contractile function: studies with normothermic and hypothermic global ischaemia. J Mol Cell Cardiol 24: 1113-1123, 1992.
63. Chambers DJ, Baimbridge MV, and Hearse DJ. Free radicals and cardioplegia: allopurinol and oxypurinol reduce myocardial injury following ischemic arrest. Ann Thorac Surg 44: 291-297, 1987.
64. Chandrasekar B, Smith JB, and Freeman GL. Ischemia-reperfusion of rat myocardium activates nuclear factor-KappaB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine. Circulation 103: 2296-2302, 2001.
65. Charlat ML, O'Neill PG, Egan JM, Abernethy DR, Michael LH, Myers ML, Roberts R, and Bolli R. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium. Am J Physiol Heart Circ Physiol 252: H566-H577, 1987.
66. Chien GL, Wolff RA, Davis RF, and Vanwinkle DM. " Normothermic-range" temperature affects myocardial infarct size. Cardiovasc Res 28: 1014-1017, 1994.
67. Claeys MJ, Vrints CJ, Bosmans JM, Conraads VM, and Snoeck JP. Aminophylline inhibits adaptation to ischaemia during coronary angioplasty. Eur Heart J 17: 539-544, 1996.
68. Clerk A, Fuller SJ, Michael A, and Sugden PH. Stimulation of "stress-regulated" mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogenactivated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 273: 7228-7234, 1998.
69. Clerk A and Sugden PH. The p38-MAPK inhibitor, SB203580, inhibits cardiac stress-activated protein kinases/c-Jun N-terminal kinases (SAPKs/JNKs). FEBS Lett 426: 93-96, 1998.
70. Cleveland JC, Meldrum DR, Cain BS, Banerjee A, and Harken AH. Oral sulphonylurea hypoglyccemic agents prevent ischemic preconditionig in human myocardium. Circulation 96: 29-32, 1997.
71. + channel. J Mol Cell Cardiol 29: 175-182, 1997.
72. ATP channel. Annu Rev Physiol 62: 79-109, 2000.
73. Cohen MV, Liu GS, and Downey JM. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84: 341-349, 1991.
74. Cohen MV, Yang X-M, and Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res 74: 998-1004, 1994.
75. Cohen MV, Yang X-M, and Downey JM. Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon. Basic Res Cardiol 92: 426-434, 1997.
76. ATP channels. Circ Res 89: 273-278, 2001.
77. Cohen MV, Yang X-M, Neumann T, Heusch G, and Downey JM. Favorable remodeling enhances recovery of regional myocardial function in the weeks after infarction in ischemically preconditioned hearts. Circulation 102: 579-583, 2000.
78. Cope DK, Impastato WK, Cohen MV, and Downey JM. Volatile anesthetics protect the ischemic rabbit myocardium from infarction. Anesthesiology 86: 699-709, 1997.
79. ATP channels with glibenclamide does not abolish preconditioning during demand ischemia. Am J Cardiol 79: 75-78, 1997.
80. Cortina A, Ambrose JA, Prieto-Granada J, Morris C, Simarro E, Holt J, and Fuster V. Left ventruicular function after myocardial infarction: clinical and angiographic correlations. J Am Coll Cardiol 5: 619-624, 1985.
81. Cribier A, Korsatz L, Koning R, Rath P, Gamra H, Stix G, Merchant S, Chan C, and Letac B. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 20: 578-586, 1992.
82. Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, and Lee JC. Sb 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and intelieukin-1. FEBS Lett 364: 229-233, 1995.
83. Cumming DVE, Heads RJ, Brand NJ, Yellon DM, and Latchman DS. The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes. Basic Res Cardiol 91: 79-85, 1996.
84. Cupples LA, Gagnon DR, Wong ND, Ostfeld AM, and Kannel WB. Pre-existing cardiovascular conditions and long term prognosis after initial myocardial infarction: the Framingham study. Am Heart J 125: 863-872, 1993.
85. 1 receptor activation maintains rabbit myocardium in a preconditioned state. J Am Coll Cardiol 31: 1142-1149, 1998.
86. Dana A, Baxter GF, and Yellon DM. Delayed or second window preconditioning induced by adenosine A1 receptor activation is independant of early generation of nitric oxide or late induction of inducible nitric oxide synthase. J Cardiovasc Pharmacol 38: 278-287, 2001.
87. 1 receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. Circulation 101: 2841-2848, 2000.
88. 1 receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 86: 989-997, 2000.
89. Dana A and Yellon DM. Cardioprotection by preinfarct angina: is it ischaemic preconditioning? Eur Heart J 19: 367-369, 1998.
90. Dana A and Yellon DM. ATP dependant K channel: a novel therapeutic target in unstable angina. Eur Heart J 20: 5, 1999.
91. Datta SR, Brunet A, and Greenburg ME. Cellular survival: a play in three Akts. Genes Dev 13: 2905-2927, 1999.
92. Dawn B, Xuan Y-T, Qiu Y, Takano H, Tang X-L, Ping P, Banerjee S, Hill M, and Bolli R. Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. Circ Res 85: 1163, 1999.
93. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW Jr, Herrmann HC, and Laskey WK. Adaptation to ischemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 82: 2044-2051, 1990.
94. Diaz RJ, Losito VA, Mao GD, Ford MK, Backx PH, and Wilson GJ. Chloride channel inhibition blocks the protection of ischemic preconditioning and hypo-osmotic stress in rabbit ventricular myocardium. Circ Res 84: 763-775, 1999.
95. Dillmann WH, Mehta HB, Barrieux A, Guth BD, Neely WE, and Ross JJ. Ischemia of the dog heart induces the appearance of a cardiac mRNA coding for a protein with migration characteristics similar to heat-shock/stress protein 71. Circ Res 59: 110-114, 1986.
96. Dos Santos P, Kowaltowski AJ, Laclau MN, Seetharaman S, Paucek P, Boudina S, Tariosse L, and Garlid KD. Mechanisms by which opening the mitochondrial ATP-sensitive K(+) channel protects the ischemic heart. Am J Physiol Heart Circ Physiol 283: H284-H295, 2002.
97. Downey JM. Free radicals and their involvement during long-term myocardial ischemia and reperfusion. Annu Rev Physiol 52: 487-504, 1990.
98. Downey JM, Hearse DJ, and Yellon DM. The role of xanthine oxidase during myocardial ischemia in several species including man. J Mol Cell Cardiol 20 Suppl II: 55-63, 1988.
99. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
100. Dupouy P, Geschwind H, Pelle G, Apteacr E, Hittinger L, El Ghalid A, and Dubois-Randej L. Repeated coronary artery occlusions during routine balloon angioplasty do not induce myocardial preconditioning in humans. J Am Coll Cardiol 27: 1374-1380, 1996.
101. Eaton P, Awad WI, Miller JIA, Hearse DJ, and Shattock MJ. Ischemic preconditioning: a potential role for constitutive low molecular weight stress protein translocation and phosphorylation? J Mol Cell Cardiol 32: 961-971, 2000.
102. Ebrahim Z, Yellon DM, and Baxter GF. Bradkinin induces delayed cardioprotection in rat heart via a nitric oxide dependent mechanism. Am J Physiol Heart Circ Physiol 281: H1458-H1464, 2001.
103. Edwards G and Weston AH. Katp-fact or artefact? New thoughts on the mode of action of the potassium channel openers. Cardiovasc Res 28: 735-737, 1994.
104. Eltchaninoff H, Cribier A, Tron C, Derumeaux G, Koning R, Hecketsweiller B, and Letac B. Adaptation to myocardial ischemia during coronary angioplasty demonstrated by clinical, electrocardiographic, echocardiographic, and metabolic parameters. Am Heart J 133: 490-506, 1997.
105. ATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration. Circulation 95: 2297-2301, 1996.
106. Eyers PA, Van Den Ijssel P, Quinlan RA, Goedert M, and Cohen P. Use of a drug-resistant mutant of stress-activated protein kinase 2a/p38 to validate the in vivo specificity of SB 203580. FEBS Lett 21: 191-196, 1999.
107. Fenton RA, Dickson EW, Meyer TE, and Dobson GJ Jr. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol 32: 1371-1375, 2000.
108. Ferrari R, Cargnoni A, Bernocchi P, Pasini E, Curello S, Ceconi C, and Ruigrok TJ. Metabolic adaptation during a sequence of no-flow and low-flow ischemia. A possible trigger for hibernation. Circulation 94: 2587-2596, 1996.
109. Forbes RA, Steenbergen C, and Murphy E. Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism. Circ Res 88: 802-809, 2001.
110. ATP channels. Circ Res 84: 846-851, 1999.
111. Fryer RM, Hsu AK, and Gross GJ. Erk and p38MAP kinase activation are components of opioid induced delayed cardioprotection. Basic Res Cardiol 96: 136-142, 2001.
112. Fryer RM, Schultz JEJ, Hsu AK, and Gross GJ. Importance of PKC and tyrosine kinase in single or multiple cycles of preconditioning in rat hearts. Am J Physiol Heart Circ Physiol 276: H1229-H1235, 1999.
113. Ganote CE and Vander Heide RS. Cytoskeletal lesions in anoxic myocardial injury: a conventional and high voltage electron microscopic and immunofluorescence study. Am J Pathol 129: 327-344, 1987.
114. Garcia-Dorado D, Ruiz-Meana M, Padilla F, Rjodriguez-Sinovas A, and Mirabet M. Gap-junction mediated intercellular communication in ischemic preconditioning. Cardiovasc Res 55: 456-465, 2002.
115. ATP in the heart: what happens, and what does not happen. Basic Res Cardiol 95: 275-279, 2000.
116. + channels: possible mechanism of cardioprotection. Circ Res 81: 1072-1082, 1997.
117. ATP channel as a receptor for potassium channel openers. J Biol Chem 271: 8796-8799, 1996.
118. Gelpi RJ, Morales C, Cohen MV, and Downey JM. Xanthine oxidase contributes to preconditioning's preservation of left ventricular developed pressure in isolated rat heart: developed pressure may not be an appropriate end-point for studies of preconditioning. Basic Res Cardiol 97: 40-46, 2002.
119. ATP channels as effectors of human myocardial preconditioning. Cardiovasc Res 45: 934-940, 2000.
120. Ghosh S, Standen N, and Galiñanes M. Preconditioning the human myocardium by simulated ischemia: studies on the early and delayed protection. Cardiovasc Res 45: 339-350, 2000.
121. 2+ and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain. Proc Natl Acad Sci USA 86: 6758-6762, 1989.
122. Goto M, Cohen MV, Van Wylen DGL, and Downey JM. Attenuated purine production during subsequent ischemia in preconditioned rabbit myocardium is unrelated to the mechanism of protection. J Mol Cell Cardiol 28: 447-454, 1996.
123. Goto M, Liu Y, Yang X-M, Ardell JL, Cohen MV, and Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 77: 611-621, 1995.
124. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, and Engler RL. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
125. Gou Y, Bao W, Wu W-J, Shinmura K, Tang X-L, and Bolli R. Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischaemic preconditioning in mice. Basic Res Cardiol 95: 479-484, 2000.
126. Gray MO, Karliner JS, and Mochly-Rosen D. A selective ε-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death. J Biol Chem 272: 30945-30951, 1997.
127. Gres P, Heusch G, Skyschally A, and Schulz R. Activation of ATP-dependent potassium channels is trigger but not mediator of ischemic preconditioning in pigs (Abstract). Circulation 106: II-265, 2002.
128. Gres P, Schulz R, Jansen J, Umschlag C, and Heusch G. Involvement of endogenous prostaglandins in ischemic preconditioning in pigs. Cardiovasc Res 55: 626-632, 2002.
129. Griffiths EJ and Halestrap AP. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J Mol Cell Cardiol 25: 1461-1469, 1993.
130. Gross GJ and Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223-233, 1992.
131. + channels and myocardial preconditioning. Circ Res 84: 973-979, 1999.
132. 1-receptors. Circulation 86: 1310-1316, 1992.
133. Guay J, Lambert H, Gingras-Breton G, Lavoie JN, Huot J, and Landry J. Regulation of actin filament dynamics by p38 map kinase-mediated phosphorylation of heat shock protein 27. J Cell Sci 110: 357-368, 1997.
134. Guo Y, Jones WK, Xuan Y-T, Tang X-L, Bao W, Wu W-J, Han H, Laubach V, Ping P, Yang Z, Qiu Y, and Bolli R. The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci USA 99: 11507-11512, 1999.
135. Guo Y, Wu W-J, Qiu Y, Tang X-L, Yang Z, and Bolli R. Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol Heart Circ Physiol 275: H1375-H1387, 1998.
136. Halestrap AP, Kerr PM, Javadov S, and Woodfield KY. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim Biophys Acta 1366: 79-94, 1998.
137. Hata K, Whittaker P, Kloner RA, and Przyklenk K. Brief antecedent ischemia attenuates platelet-mediated thrombosis in damaged and stenotic canine coronary arteries: role of adenosine. Circulation 97: 692-702, 1998.
138. Hausenloy D J, Maddock HL, Baxter GF, and Yellon DM. Inhibiting mitochondrial permeability transition pore opening: a new paradigm in myocardial preconditioning. Cardiovasc Res 55: 534-543, 2002.
139. Heads RJ, Latchman DS, and Yellon DM. Stable high level expression of a transfected human HSP70 gene protects a heart-derived muscle cell line against thermal stress. J Mol Cell Cardiol 26: 695-699, 1994.
140. Heusch G. Nitroglycerin and delayed preconditioning in humans: yet another new mechanism for an old drug? Circulation 103: 2876-2878, 2001.
141. Heusch G, Liu GS, Rose J, Cohen MV, and Downey JM. No confirmation for a causal role of volume-regulated chloride channels in ischemic preconditioning in rabbits. J Mol Cell Cardiol 32: 2279-2285, 2000.
142. Holly T, Nakamura S, Yaroshenko Y, Decker RS, Decker ML, Harris KR, and Klocke FJ. Ischemic preconditioning causes translocation of constitutive αB-crystallin and HSP27 to myofibrils and/or the cytoskeleton in rabbits (Abstract). FASEB J 13: A1065, 1999.
143. Holly TA, Drincic A, Byun Y, Nakamura S, Harris K, Klocke FJ, and Cryns VL. Caspase inhibition reduces myocyte cell death induced by myocardial ischemia and reperfusion in vivo. J Mol Cell Cardiol 31: 1709-1715, 2002.
144. + channels modulate cardiac mitochondrial function. Am J Physiol Heart Circ Physiol 275: H1567-H1576, 1998.
145. 2+ overload in rat cardiac mitochondria. J Physiol 519: 347-360, 1999.
146. Hoshida S, Kuzuya T, Fuji H, Yamashita N, Oe H, Hori M, Suzuki K, Taniguchi N, and Tada M. Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol Heart Circ Physiol 264: H33-H39, 1993.
147. Huot J, Houle F, Spitz DR, and Landry J. Hsp27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer Res 56: 273-279, 1996.
148. Ikonomidis JS, Shirai T, Weisel RD, Derylo B, Rao V, Whiteside CI, Mickle DAG, and Li R-K. Preconditioning cultured human pediatric myocytes requires adenosine and protein kinase C. Am Physiol Heart Circ Physiol 272: H1220-H1230, 1997.
149. Ikonomidis JS, Tuniati LC, Weisel RD, Mickle DA, and Li RK. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res 28: 1285-1291, 1994.
150. Iliodromitis EK, Miki T, Liu GS, Downey JM, Cohen MV, and Kremastinos DT. The PKC activator PMA preconditions rabbit heart in the presence of adenosine receptor blockade: is 5′-nucleotidase important? J Mol Cell Cardiol 30: 2201-2211, 1998.
151. Illes RW and Sowyer KD. Prospective randomized clinical study of ischemic preconditioning as an adjunct to intermittant cold blood cardioplegia. Ann Thor Surg 65: 748-753, 1998.
152. Imagawa J, Baxter GF, and Yellon DM. Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J Mol Cell Cardiol 29: 1885-1893, 1997.
153. Ishida T, Yarimizu K, Gute DC, and Korthuis RJ. Mechanisms of ischemic preconditioning. Shock 8: 86-94, 1997.
154. Ishihara M, Sato H, Tateishi H, Kawagoe T, Shimatani Y, Kurisu S, Sakai K, and Ueda K. Implications of prodromal angina pectoris in anterior wall acute myocardial infarction: acute angiographic findings and long term prognosis. J Am Coll Cardiol 30: 970-975, 1997.
155. Iwasaka T, Nakamura S, Karakawa M, Sugiura T, and Inada M. Cardioprotective effect of unstable angina prior to acute anterior myocardial infarction. Chest 105: 57-61, 1994.
156. Jaberansari MT, Baxter GF, Muller CA, Latouf SE, Roth E, Opie LH, and Yellon DM. Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. J Am Coll Cardiol 37: 1996-2001, 2001.
157. Javadov S, Lim K, Kerr P, Suleiman M, Angelini G, and Halestrap AP. Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45: 360-369, 2000.
158. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, and Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 77: 314-318, 1997.
159. Jenkins DP, Pugsley WB, and Yellon DM. Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. J Mol Cell Cardiol 27: 1623-1632, 1995.
160. Jennings RB and Reimer KA. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood. Circulation 68 Suppl 1: I-25-I-36, 1983.
161. Jimenez-Navarro M, Gomez-Doblas JJ, Alonso-Briales J, Hernandez Garcia JM, Gomez G, Alcantara AG, Rodriguez-Bailon I, Barrera A, Espinosacaliani JS, and De Teresa E. Does angina the week before protect against first myocardial infarction in elderley patients? Am J Cardiol 87: 11-15, 2001.
162. Johnson JA, Gray MO, Chen C-H, and Mochly-Rosen D. A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function. J Biol Chem 271: 24962-24966, 1996.
163. Jordan JE, Zhao Z-Q, and Vinten-Johansen J. The role of neutrophils in myocardial ischemia-reperfusion injury. Cardiovasc Res 43: 860-878, 1999.
164. Joyeux M, Godin-Ribuot D, and Ribuot C. Resistance to myocardial infarction induced by heat stress and the effect of ATP-sensitive potassium channel blockade in the rat isolated heart. Br J Pharmacol 125: 108.5-1088, 1998.
165. + exchanger isoforms (NHE-1, -2, and -3) are differentially responsive to second messenger agonists of the protein kinase A and C pathways. J Biol Chem 270: 29209-29216, 1995.
166. a. Karck M, Rahmanian P, and Haverick A. Ischemic preconditioning enhances donor heart preservation. Transplantation 62: 17-22, 1996.
167. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res 27: 915-924, 1993.
168. Karsch M, Baufreton C, Fernandez C, Brunet S, Pasteau F, Astier A, and Loisance DY. Preconditioning with cromokalim improves long-term myocardial preservation for heart transplantation Ann Thorac Surg 66: 417-424, 1998.
169. Kaukoranta P, Lepojarvi MPK, Ylitalo KV, Kiviluoma KT, and Peuhkurinen KJ. Normothermic retrograde blood cardioplegia with or without preceding ischemic preconditioning. Ann Thorac Surg 63: 1268-1274, 1997.
170. Kerensky RA, Franco E, Schlaifer JD, Pepine CJ, and Belardinelli L. Effect of theophylline on the warm up phenomenon. Am J Cardiol 84: 1077-1080, 1999.
171. Kevelaitis E, Peynet J, Mouas C, Launay J-M, and Menasche P. Opening of potassium channels: the common cardioprotective link between preconditioning and natural hibernation. Circulation 99: 3079-3085, 1999.
172. Kim SO, Baines CP, Critz SD, Pelech SL, Katz S, Downey JM, and Cohen MV. Ischemia induced activation of heat shock protein 27 kinases and casein kinase 2 in the preconditioned rabbit heart. Biochem Cell Biol 77: 559-567, 1999.
173. Kirino T. Ischemic tolerance. J Cereb Blood Flow Metab 22: 1283-1296, 2002.
174. 1 receptors by G proteins in rat ventricular myocytes. Am J Physiol Heart Circ Physiol 259: H820-H826, 1990.
175. Kitakaze M, Hori M, Morioka T, Minamino T, Takashima S, Sato H, Shinozaki Y, Chujo M, Mori H, Inoue M, and Kamada T. Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5′-nucleotidase activity and attenuation of adenosine release. Circulation 89: 1237-1246, 1994.
176. Klein HH, Puschmann S, Schaper J, and Schaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch 393: 287-297, 1981.
177. Kloner RA, Bolli R, Marban E, Reinlib L, and Braunwald E. Medical and cellular implications of stunning, hibernation and preconditioning: an NHLBI workshop, Circulation 97: 1848-1867, 1998.
178. Kloner RA, Przyklenk K, Shook T, and Cannon CP. Protection conferred by preinfarct angina is manifest in the aged heart: evidence from the Timi 4 Trial. J Thromb Thrombolysis 6: 89-92, 1998.
179. Kloner RA, Przyklenk K, and Whittaker P. Deleterious effects of oxygen radicals in ischemia/reperfusion: resolved and unresolved issues. Circulation 80: 1115-1127, 1989.
180. Kloner RA, Shook T, Antman EM, Cannon CP, Przyklenk K, Yoo K, Mccabe CH, Braunwald E, and The Timi-9b Investigators. Prospective temporal analysis of the onset of preinfarction angina versus outcome: an ancillary study in TIMI-9B. Circulation 97: 1042-1045, 1998.
181. Kloner RA, Shook T, Przyklenk K, Davis VG, Junio L, Matthews RV, Burstein S, Gibson CM, Poole WK, Cannon CP, McCabe CH, and Braunwald E. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 91: 37-45, 1995.
182. Knowlton AA, Brecher P, and Apstein CS. Rapid expression of heat shock protein in the rabbit after brief cardiac ischemia. J Clin Invest 87: 139-147, 1991.
183. Kodani E, Shinmura K, Xuan YT, Takano H, Auchampach JA, Tang XL, and Bolli R. Cyclooxygenase-2 does not mediate late preconditioning induced by activation of adenosine A1 or A3 receptors. Am J Physiol Heart Circ Physiol 281: H959-H668, 2002.
184. Kolocassides KG, Seymour A-ML, Galiñanes M, and Hearse DJ. Paradoxical effect of ischemic preconditioning on ischemic contracture? NMR studies of energy metabolism and intracellular pH in the rat heart. J Mol Cell Cardiol 28: 1045-1057, 1996.
185. + channels. Circulation 93: 178-186, 1996.
186. Kostitprapa C, Ockaili RA, and Kukreja RC. Bradykinin B2 receptor is involved in the late phase of preconditioning in rabbit heart. J Mol Cell Cardiol 33: 1355-1362, 2001.
187. Krenz M, Baines CP, Yang X-M, Heusch G, Cohen MV, and Downey JM. Acute ethanol exposure fails to elicit preconditioning-like protection in in situ rabbit hearts because of its continued presence during ischemia. J Am Coll Cardiol 37: 601-607, 2001.
188. Krenz M, Oldenburg O, Wimpee H, Cohen MV, Garlid KD, Critz S, Downey JM, and Benoit JN. Opening of ATP-sensitive potassium channels causes generation of free radicals in vascular smooth muscle cells. Basic Res Cardiol 97: 365-373, 2002.
189. Kusama Y, Bernier M, and Hearse DJ. Exacerbation of reperfusion arrhythmias by sudden oxidant stress. Circ Res 67: 481-489, 1990.
190. Kuzuya T, Hoshida S, Yamashita N, Fuji H, Oe H, Hori M, Kamada T, and Tada M. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res 72: 1293-1299, 1993.
191. Laclau MN, Boudina S, Thambo JB, Tariosse L, Gouverneur G, Bonoron-Adèle S, Saks VA, Garlid KD, and Dos Santos P. Cardioprotection by ischemic preconditioning preserves mitochondrial function and functional coupling between adenine nucleotide translocase and creatine kinase. J Mol Cell Cardiol 33: 947-956, 2001.
192. Landymore RW, Bayes AJ, Murphy JT, and Fris JH. Preconditioning prevents myocardial stunning after cardiac transplantation. Ann Thorac Surg 66: 1953-1957, 1998.
193. Lasley RD and Mentzer RM. Adenosine improves recovery of postischemic myocardial function via an adenosine A1 receptor mechanism. Am J Physiol Heart Circ Physiol 263: H1460-H1465, 1992.
194. Lawson CS and Downey JM. Preconditioning: state of the art myocardial protection. Cardiovasc Res 27: 542-550, 1993.
195. Lee HT, Lafaro RJ, and Reed GE. Pretreatment of human myocardium with adenosine during open heart surgery. J Cardiac Surg 10: 665-676, 1995.
196. Lee TM, Su SF, Chou TF, Lee YT, and Tsai CH. Loss of preconditioning by attenuated activation of myocardial ATP sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation 105: 334-340, 2002.
197. Leesar MA, Stoddard M, Ahmed M, Broadbent J, and Bolli R. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation 95: 2500-2507, 1997.
198. Leesar MA, Stoddard MF, Dawn B, Jasti VG, Masden R, and Bolli R. Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation 103: 2935-2941, 2001.
199. Leesar MA, Stoddard MF, Manchikalapudi S, and Bolli R. Bradykinin-induced preconditioning in patients undergoing coronary angioplasty. J Am Coll Cardiol 34: 639-650, 1999.
200. Li G, Chen S, Lu E, and Li Y. Ischemic preconditioning improves preservation with cold blood cardioplegia in valve replacement patients. Eur J Cardiothoracic Surg 15: 653-657, 1999.
201. Li G, Whittaker P, Yao M, Kloner RA, and Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts. Cardiovasc Pathol 11: 158-165, 2002.
202. Li GC, Vasquez JA, Gallagher KP, and Lucchesi BR. Myocardial protection with preconditioning. Circulation 82: 609-619, 1990.
203. Li Y and Kloner RA. Cardioprotective effects of ischemic preconditioning are not mediated by prostanoids. Cardiovasc Res 26: 226-231, 1992.
204. ATP channels. Circ Res 84: 1396-1400, 1999.
205. Liu GS, Cohen MV, Mochly-Rosen D, and Downey JM. Protein kinase C-ε is responsible for the protection of preconditioning in rabbit cardiomyocytes. J Mol Cell Cardiol 31: 1937-1948, 1999.
206. 3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart. Cardiovasc Res 28: 1057-1061, 1994.
207. Liu GS, Stanley AWH, and Downey J. Cyclooxygenase products are not involved in the protection against myocardial infarction afforded by preconditioning in rabbit. Am J Cardiovasc Pathol 4: 56-63, 1992.
208. 1 adenosine receptors in rabbit heart. Circulation 84: 350-356, 1991.
209. ATP channels. Mol Pharmacol 59: 225-230, 2001.
210. Liu Y, Sato T, O'Rourke B, and Marban E. Mitochondrial ATP-dependent potassium channels: novel effectors of cardioprotection? Circulation 97: 2463-2469, 1998.
211. Liu Y, Ytrehus K, and Downey JM. Evidence that translocation of protein kinase C is a key event during ischemic preconditioning of rabbit myocardium. J Mol Cell Cardiol 26: 661-668, 1994.
212. Lu HR, Remeysen P, and De Clerck F. Does the antiarrhythmic effect of ischemic preconditioning in rats involve the L-arginine nitric oxide pathway? J Cardiovasc Pharmacol 25: 524-530, 1995.
213. Ma X-L, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, and Yue T-L. Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion. Circulation 99: 1685-1691, 1999.
214. Marber MS, Joy MD, and Yellon DM. Editorial. Warm-up angina: is it ischaemic preconditioning. Br Heart J 72: 213-215, 1994.
215. Marber MS, Latchman DS, Walker JM, and Yellon DM. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation 88: 1264-1272, 1993.
216. Marber MS, Mestril R, Chi SH, Sayen R, Yellon DM, and Dillmann WH. Overexpression of rat inducible 70-kD heat stress protein in a transgenic mouse increases resistance of the heart to ischaemic injury. J Clin Invest 95: 1446-1456, 2002.
217. Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J Jr, and Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation 43: 67-82, 1971.
218. Maroko PR, Libby P, Bloor CM, Sobel BE, and Braunwald E. Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation 46: 430-437, 1972.
219. Maroko PR, Libby P, Sobel BE, Bloor CM, Shell WE, Covell JW, and Braunwald E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion. Circulation 45: 1160-1175, 1972.
220. Mason MJ, Patel DJ, Paul V, and Ilsley CD. Time course and extent of collateral vessel recruitment during coronary angioplasty. Coron Artery Dis 13: 17-23, 2002.
221. Matsuyama N, Leavens JE, McKinnon D, Gaudette GR, Aksehirli TO, and Krukenkamp IB. Ischemic but not pharmacological preconditioning requires protein synthesis. Circulation 102 Suppl 3: III-312-III-318, 2000.
222. Maulik N, Watanabe M, Zu Y-L, Huang C-K, Cordis GA, Schley JA, and Das DK. Ischemic preconditioning triggers the activation of MAP kinases and MAPKAP kinase 2 in rat hearts. FEBS Lett 396: 233-237, 1996.
223. Maulik N, Yoshida T, Zu Y-L, Sato M, Banerjee A, and Das DK. Ischemic preconditioning triggers tyrosine kinase signaling: a potential role for MAPKAP kinase 2. Am J Physiol Heart Circ Physiol 275: H1857-H1864, 1998.
224. ATP channels mediate late preconditioning against infarction produced by monophosphory lipid A. Am J Physiol Heart Circ Physiol 271: H2723-H2729, 1996.
225. Meldrum DR, Cain BS, Cleveland JC Jr, Meng X, Ayala A, Banerjee A, and Harken AH. Adenosine decreases post-ischaemic cardiac TNF-alpha production: anti-inflammatory implications for preconditioning and transplantation. Immunology 92: 472-477, 1997.
226. Meng X, Brown JM, Ao L, Banerjee A, and Harken AH. Norepinephrine induces cardiac heat shock protein 70 and delayed cardioprotection in the rat through α1 adrenoceptors. Cardiovasc Res 32: 374-383, 1996.
227. Meng X, Shames BD, Pulido EJ, Meldrum DR, Ao L, Joo KS, Harken AH, and Banerjee A. Adrenergic induction of bimodal myocardial protection: signal transduction and cardiac gene reprogramming. Am J Physiol Regul Integr Comp Physiol 276: R1525-R1533, 2002.
228. Michel MC, Li Y, and Heusch G. Mitogen-activated protein nases in the heart. Naunyn-Schmiedebergs Arch Pharmacol 363: 245-266, 2001.
229. Miki T, Miura T, Shimamoto K, Urabe K, Sakamoto J, and Iimura O. Do angiotensin converting enzyme inhibitors limit myocardial infarct size. Clin Exp Pharm Physiol 20: 429-434, 1993.
230. a. Minners J, Van Den Bos EJ, Yellon DM, Schwalb H, Opie LH, and Sack MN. Dinitrophenol, cyclosporin-A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res 47: 68-73, 2000.
231. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, and Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 76: 73-81, 1995.
232. 2+ as a mediator of ischemic preconditioning. Circ Res 80: 790-799, 1997.
233. Miyawaki H, Zhou X, and Ashraf M. Calcium preconditioning elicits strong protection against ischemic injury via protein kinase C signaling pathway. Circ Res 79: 137-146, 1996.
234. Mocanu MM, Baxter GF, and Yellon DM. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol 130: 197-200, 2000.
235. Mocanu MM, Baxter GF, Yue Y, Critz SD, and Yellon DM. The p38 MAPK inhibitor, SB203580, abrogates ischaemic precondition ing in rat heart but timing of administration is critical. Basic Res Cardiol 95: 472-478, 2000.
236. Mocanu MM, Bell RM, and Yellon DM. PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. J Mol Cell Cardiol 34: 661-668, 2002.
237. Mocanu MM, Maddock HL, Baxter GF, Lawrence CL, Standen NB, and Yellon DM. Glimepiride, a novel sulphonyurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide. Circulation 103: 3111-3116, 2002.
238. Mockridge JW, Punn A, Latchman DS, Marber MS, and Heads RJ. PKC-dependent delayed metabolic preconditioning is independent of transient MAPK activation. Am J Physiol Heart Circ Physiol 279: H492-H501, 2000.
239. Morris SD and Yellon DM. Angiotensin-converting enzyme inhibitors potentiate preconditioning through bradykinin B2 receptor activation in human heart. J Am Coll Cardiol 29: 1599-1606, 1997.
240. Murphy E, Glasgow W, Fralix T, and Steenbergen C. Role of lipoxygenase metabolites in ischemic preconditioning. Circ Res 76: 457-467, 1995.
241. Murray CJ and Lopez AD. Alternate projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 349: 1498-1504, 1997.
242. Murry CE, Jennings RB, and Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74: 1124-1136, 1986.
243. Murry CE, Richard VJ, Jennings RB, and Reimer KA. Myocardial protection is lost before contractile function recovers from ischemic preconditioning. Am J Physiol Heart Circ Physiol 260: H796-H804, 1991.
244. Murry CE, Richard VJ, Reimer KA, and Jennings RB. Ischemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischemic episode. Circ Res 66: 913-931, 1990.
245. Nagarkatti DS and Sha'afi RI. Role of p38 MAP kinase in myocardial stress. J Mol Cell Cardiol 30: 1651-1664, 1998.
246. Nakamura M, Wang NP, Zhao ZQ, Wilcox JN, Thourani VH, Guyton RA, and Vinten-Johansen J. Preconditioning decreases Bax expression, PMN accumulation and apoptosis in reperfused rat heart. Cardiovasc Res 45: 661-670, 2002.
247. Nakano A, Baines CP, Kim SO, Pelech SL, Downey JM, Cohen MV, and Critz SD. Ischemic preconditioning activates MAP-KAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK. Circ Res 86: 144-151, 2000.
248. Nakano A, Cohen MV, Critz S, and Downey JM. Sb 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts. Basic Res Cardiol 95: 466-471, 2000.
249. Nakano A, Heusch G, Cohen MV, and Downey JM. Preconditioning one myocardial region does not necessarily precondition the whole rabbit heart. Basic Res Cardiol 97: 35-39, 2001.
250. Nakano A, Liu GS, Heusch G, Downey JM, and Cohen MV. Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. J Mol Cell Cardiol 32: 1159-1167, 2000.
251. Napoli C, Liguori A, Chiariello M, Di Leso N, Condorelli M, and Ambrosio G. New-onset angina preceding acute myocardial infarction is associated with improved contractile recovery after thrombolysis. Eur Heart J 19: 411-419, 1998.
252. Noma A. ATP-regulated potassium channels in cardiac muscle. Nature 305: 147-148, 1983.
253. ATP channel induces early and delayed cardioprotective effect: role of nitric oxide. Am J Physiol Heart Circ Physiol 277: H2425-H2434, 1999.
254. a. Ohno M, Takemura G, Ohno A, Misao J, Hayakawa Y, Minatoguchi S, Fujiwara T, and Fujiwara H. Apoptotic myocytes in infarct area in rabbit hearts may be oncotic myocytes with DNA fragmentation analysis by immunogold electron microscopy combined with in situ nick end-labeling. Circulation 98: 1422-1430, 1998.
255. Okamura T, Miura T, Takemura G, Fujiwara H, Iwamoto H, Kawamura S, Kimura M, Ikeda Y, Iwatate M, and Matsuzaki M. Effect of caspase inhibitors on myocardial infarct size and myocyte DNA fragmentation in the ischemia-reperfused rat heart. Cardiovasc Res 45: 642-650, 2000.
256. Okazaki Y, Kodama. K, Sato H, Kitakaze M, Hirayame A, Mishima M, Hori M, and Inoue M. Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm-up. J Am Coll Cardiol 21: 1597-1604, 1993.
257. Okishige K, Yamashita K, Yoshinaga H, Azegami K, Satoh T, Goseki Y, Fujii S, Ohira H, and Satake S. Electrophysiologic effects of ischemic preconditioning on QT dispersion during coronary angioplasty. J Am Coll Cardiol 28: 70-73, 1996.
258. i proteins, phosphatidylinositol 3-kinase and tyrosine kinase. Cardiovasc Res 55: 544-552, 2002.
259. Ottani F, Galvani M, Ferrini D, Sorbello F, Limonetti P, Pantoli D, and Rusticali F. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 91: 291-297, 1995.
260. Ovize M, Aupetit J, Rioufol G, Loufoua J, Andre-Fouet X, Minaire Y, and Fuacon G. Preconditioning reduces infarct size but accelerates time to ventricular fibrillation in ischemic pig heart. Am J Physiol Heart Circ Physiol 269: H72-H79, 1995.
261. Ovize M, Kloner RA, and Przyklenk K. Stretch preconditions canine myocardium. Am J Physiol Heart Circ Physiol 266: H137-H146, 1994.
262. Ovize M, Przyklenk K, Hale SL, and Kloner RA. Preconditioning does not attenuate myocardial stunning. Circulation 85: 2247-2254, 1992.
263. ATP channel blocker, on warm-up phenomenon in type II diabetic patients with chronic stable angina. Clin Cardiol 23: 535-539, 2000.
264. ATP channels triggers the preconditioned state by generating free radicals. Circ Res 87: 460-466, 2000.
265. Pang CY, Neligan P, Zhong A, He W, Xu H, and Forrest CR. Effector mechanism of adenosine in acute ischemic preconditioning of skeletal muscle against infarction. Am J Physiol Regul Integr Comp Physiol 273: R887-R895, 1997.
266. Pang CY, Yang RZ, Zhong A, Xu N, Boyd B, and Forrest CR. Acute ischaemic preconditioning protects against skeletal muscle infarction in the pig. Cardiovasc Res 29: 782-788, 1995.
267. Parratt JR, Vegh A, Kaszala K, and Papp JG. Protection by preconditioning and cardiac pacing against ventricular arrhythmias resulting from ischemia and reperfusion. Ann NY Acad Sci 793: 98-107, 1996.
268. Patel D J, Purcell H, and Fox KM. Cardioprotection by opening of the KATP channel in unstable angina: is this a clinical manifestation of myocardial preconditioning? Results of a randomised study with nicorandil CESAR 2 investigation Clinical European studies in angina and revsacularization. Eur Heart J 20: 51-57, 1999.
269. Patel HH, Hsu A, Moore J, and Gross GJ. Bw373u86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J Mol Cell Cardiol 33: 1455-1465, 2001.
270. Patel HH, Moore J, Hsu AK, and Gross GJ. Cardioprotection at a distance: mesenteric artery occlusion protects the myocardium via an opioid sensitive mechanism. J Mol Cell Cardiol 34: 1317-1323, 2002.
271. Pell TJ, Yellon DM, Goodwin RW, and Baxter GF. Myocardial ischemic tolerance following heat stress is abolished by ATP sensitive potassium channel blockade. Cardiovasc Drugs Ther 11: 679-686, 2002.
272. Perrault LP and Menasche P. Preconditioning: can natures shield be raised against surgical ischemic-reperfusion injury? Ann Thoracic Surg 68: 1988-1994, 1999.
273. Perrault LP, Menasché P, Bel A, De Chaumaray T, Peynet J, Mondry A, Olivero P, Emanoil-Ravier R, and Moalic J-M. Ischemic preconditioning in cardiac surgery: a word of caution. J Thoracic Cardiovasc Surg 112: 1378-1386, 1996.
274. Ping P and Murphy E. Role of p38 mitogen-activated protein kinases in preconditioning. Circ Res 86: 921, 2000.
275. Ping P, Takano H, Zhang J, Tang X-L, Qiu Y, Li RCX, Banerjee S, Dawn B, Balafonova Z, and Bolli R. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res 84: 587-604, 1999.
276. Ping P, Zhang J, Cao X, Li RCX, Kong D, Tang X-L, Qiu Y, Manchikalapudi S, Auchampach JA, Black RG, and Bolli R. PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol Heart Circ Physiol 276: H1468-H1481, 1999.
277. Ping P, Zhang J, Huang S, Cao X, Tang X-L, Li RCX, Zheng Y-T, Qiu Y, Clerk A, Sugden P, Han J, and Bolli R. PKC-dependent activation of p46/p54 JNKs during ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 277: H1771-H1785, 1999.
278. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Cao X, and Bolli R. Ischemic preconditioning induces selective translocation of protein kinase C isoforms ε and Θ in the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 81: 404-414, 1997.
279. Ping P, Zhang J, Zheng Y-T, Li RCX, Dawn B, Tang X-L, Takano H, Balafonova Z, and Bolli R. Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res 85: 542-550, 1999.
280. Piot C, Martini J-F, Bui S, and Wolfe CL. Ischemic preconditioning attenuates ischemia/reperfusion-induced activation of caspases and subsequent cleavage of poly (ADP-ribose) polymerase in rat hearts in vivo. Cardiovasc Res 44: 536-542, 1999.
281. Post H, Schulz R, Behrends M, Gres P, Umschlag C, and Heusch G. No involvement of endogenous nitric oxide in classical ischemic preconditioning in swine. J Mol Cell Cardiol 32: 725-733, 2000.
282. Przyklenk K, Bauer B, Ovize M, Kloner RA, and Whittaker P. Regional ischemic "preconditioning" protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 87: 893-899, 1993.
283. Przyklenk K, Hata K, and Kloner RA. Is calcium a mediator of infarct size reduction with preconditioning in canine myocardium? Circulation 96: 1305-1312, 1997.
284. Przyklenk K and Whittaker P. Brief antecedent ischemia enhances recombinant tissue plasminogen activator-induced coronary thrombolysis by adenosine-mediated mechanism. Circulation 102: 88-95, 2000.
285. Qian YZ, Bernado NL, Nayeem MA, Chelliah J, and Kukreja RA. Introduction of 72-kDa heat shock protein does not produce second window of ischaemic precondionting in rat heart. Am J Physiol Heart Circ Physiol 276: H224-H234, 2002.
286. Qin Q, Downey JM, and Cohen MV. Acetylcholine but not adenosine triggers preconditioning through PI3-kinase and a tyrosine kinase. Am J Physiol Heart Circ Physiol 284: H727-H734, 2003.
287. Qiu Y, Ping P, Tang X-L, Manchikalapudi S, Rizvi A, Zhang J, Takano H, Wu W-J, Teschner S, and Bolli R. Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that ε is the isoform involved. J Clin Invest 101: 2182-2198, 1998.
288. Reimer KA and Jennings RB. The "wavefront phenomenon" of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40: 633-644, 1979.
289. Reimer KA, Murry CE, and Richard VJ. The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy? J Mol Cell Cardiol 21: 1225-1239, 1989.
290. Rinaldi CA, Masani MD, Linka AZ, and Hall RJ. Effect of repetitive episodes of exercise induced myocardial ischaemia on left ventricular function in patients with chronic stable angina: evidence for cumulative stunning or ischaemic preconditioning. Heart 81: 404-411, 1999.
291. Sack S, Mohri M, Arras M, Schwarz ER, and Schaper W. Ischemic preconditioning: time course of renewal in the pig. Cardiovasc Res 27: 551-555, 1993.
292. Saito S, Mizumura T, Takayama T, Honye J, Fukui T, Kamata T, Moriuchi M, Hibiya K, Tamura Y, and Ozawa Y. Anti-ischemic effects of nicorandil during coronary angioplasty in humans. Cardiovasc Drugs Ther 9: 257-263, 1995.
293. Sakai K, Yamagata T, Teragawa H, Matsuura H, and Chayama K. Nicorandil enhances myocardial tolerance to ischemia without progressive collateral recruitment during coronary angioplasty. Circ J 66: 317-322, 2002.
294. Saltman AE, Aksehirli TO, Valiunas V, Gaudette GR, Matsuyama N, Brink P, and Krukenkamp IB. Gap junction uncoupling protects the heart against ischemia. J Thoracic Cardiovasc Surg 124: 371-376, 2002.
295. Sanada S, Kitakaze M, Papst PJ, Hatanaka K, Asanuma H, Aki T, Shinozaki Y, Ogita H, Node K, Takashima S, Asakura M, Yamada J, Fukushima T, Ogai A, Kuzuya T, Mori H, Terada N, Yoshida K, and Hori M. Role of phasic dynamism of p38 mitogen-activated protein kinase activation in ischemic preconditioning of the canine heart. Circ Res 88: 175-180, 2001.
296. Sanz E, Garcia-Dorado D, Oliveras J, Barrabes JA, Gonzalez MA, Ruiz-Meana M, Solares J, Carreras MJ, Garcia-Lafuente A, and Desco M. Dissociation between anti-infarct effect and anti-edema effect of ischemic preconditioning. Am J Physiol Heart Circ Physiol 268: H233-H241, 2002.
297. Sato H, Miki T, Vallabhapurapu RP, Wang P, Liu G-S, Cohen MV, and Downey JM. The mechanism of protection from 5(N-ethyl-N-isopropyl) amiloride differs from that of ischemic preconditioning in rabbit heart. Basic Res Cardiol 92: 339-350, 1997.
298. Sato M, Cordis GA, Maulik N, and Das DK. Sapks regulation of ischemic preconditioning. Am J Physiol Heart Circ Physiol 279: H901-H907, 2000.
299. + channels by protein kinase C. Circ Res 83: 110-114, 1998.
300. Sato T, Sasaki N, O'Rourke B, and Marban E. Nicorandil, a potent cardioprotective agent, acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol 35: 514-518, 2000.
301. ATP channels in ischemic cardioprotection. Circulation 101: 2418-2423, 2000.
302. Saurin AT, Martin JL, Heads RJ, Foley C, Mockridge JW, Wright MJ, Wang Y, and Marber MS. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J 14: 2237-2246, 2000.
303. Schaefer S, Carr LJ, Prussel E, and Ramasamy R. Effects of glycogen depletion on ischemic injury in isolated rat hearts: insights into preconditioning. Am J Physiol Heart Circ Physiol 268: H935-H944, 2002.
304. Schneider S, Chen W, Hou J, Steenbergen C, and Murphy E. Inhibition of p38 MAPK alpha/beta reduces ischemic injury and does not block protective effects of preconditioning. Am J Physiol Heart Circ Physiol 280: H499-H508, 2002.
305. Schott RJ, Rohmann S, Braun ER, and Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 66: 1133-1142, 1990.
306. Schulman D, Latchman DS, and Yellon DM. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol 281: H1630-H1636, 2001.
307. Schulz R, Post H, Sakka S, Wallbridge DR, and Heusch G. Intraischemic preconditioning: increased tolerance to sustained low-flow ischemia by a brief episode of no-flow ischemia without intermittent reperfusion. Circ Res 76: 942-950, 1995.
308. Schulz R, Post H, Vahlhaus C, and Heusch G. Ischemic preconditioning in pigs: a graded phenomenon. Its relation to adenosine and bradykinin. Circulation 98: 1022-1029, 1998.
309. Schulz R, Rose J, and Heusch G. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol Heart Circ Physiol 267: H1341-H1352, 1994.
310. Schwanke U, Konietzka I, Duschin A, Li X, Schulz R, and Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice. Am J Physiol Heart Circ Physiol 283: H1740-H1742, 2002.
311. Sekili S, Jeroudi MO, Tang X-L, Zughaib M, Sun J-Z, and Bolli R. Effect of adenosine on myocardial stunning in the dog. Circ Res 76: 82-94, 1995.
312. Shattock MJ, Lawson CS, Hearse DJ, and Downey JM. Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. J Mol Cell Cardiol 28: 1339-1347, 1996.
313. Shen YT, Fallon JT, Iwase M, and Vatner SF. Innate protection of baboon myocardium: effects of coronary artery occlusion and reperfusion. Am J Physiol Heart Circ Physiol 270: H1812-H1818, 1996.
314. Shiki K and Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol Heart Circ Physiol 253: H1470-H1476, 1987.
315. Shimizu N, Yoshiyama M, Omura T, Hanatani A, Kim S, Takeuchi K, Iwao H, and Yoshikawa J. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats. Cardiovasc Res 38: 116-124, 1998.
316. Shinmura A, Tang X-L, Xuan Y-T, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, and Bolli R. Cyclooxygenase-2 mediates the cardioprotective effect of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 97: 10197-10202, 2000.
317. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90: 602-608, 2002.
318. Shirai T, Rao V, Weisel RD, Ikonomidis JS, Li R-K, Tumiati LC, Merante F, and Mickle DA. Preconditioning human cardiomyocytes and endothelial cells. J Thoracic Cardiovasc Surg 115: 210-219, 1998.
319. Silva PH, Dillon D, and Van Wylen DGL. Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction. Cardiovasc Res 29: 616-623, 1995.
320. Smith RM, Suleman N, McCarthy J, and Sack MN. Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene. Cardiovasc Res 55: 553-560, 2002.
321. + channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 77: 1030-1035, 1995.
322. Steenbergen C, Perlman ME, London RE, and Murphy E. Mechanism of preconditioning: ionic alterations. Circ Res 72: 112-125, 1993.
323. Steeves G, Singh N, and Singal PK. Preconditioning and antioxidant defense against reperfusion injury. Ann NY Acad Sci 723: 116-127, 1994.
324. Stewart RA, Simmonds MB, and Williams MJ. Time course of warm-up in stable angina. Am J Cardiol 76: 70-73, 1995.
325. Strohm C, Barancik T, Bruhl ML, Kilian SA, and Schaper W. Inhibition of the ER-kinase cascade by PD98059 and UO126 counteracts ischemic preconditioning in pig myocardium. J Cardiovasc Pharmacol 36: 218-229, 2002.
326. Sumeray MS and Yellon DM. Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium. Basic Res Cardiol 93: 384-390, 1998.
327. Sun J-Z, Tang X-L, Knowlton AA, Park S-W, Qiu Y, and Bolli R. Late preconditioning against myocardial stunning: an endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest 95: 388-403, 1995.
328. Sun J-Z, Tang X-L, Park S-W, Qiu Y, Turrens JF, and Bolli R. Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest 97: 562-576, 1996.
329. Suzuki M, Sasaki N, Miki T, Sakamoto N, Ohmoto-Sekine Y, Tamagawa M, Seino S, Marban E, and Nakaya H. Role of sarcolemmal K(ATP) channels in cardioprotection against ischemia/reperfusion injury in mice. J Clin Invest 109: 509-516, 2002.
330. Szekeres L, Balint Z, Karescu S, Tosaki A, and Udvary E. On the 7-oxo-PG12 induced late appearing long lasting cytoprotective effect. Prog Clin Biol Res 301: 143-147, 1989.
331. 3 adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res 88: 520-528, 2001.
332. Takano H, Manchikalapudi S, Tang X-L, Qiu Y, Rizvi A, Jadoon AK, Zhang Q, and Bolli R. Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation 98: 441-449, 1998.
333. Takano H, Tang X-L, Qiu Y, Guo Y, French BA, and Bolli R. Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res 83: 73-84, 1998.
334. Takano H, Tang X-L, and Bolli R. Differential roles of KATP channels in late preconditioning against myocardial stunning and infarction in rabbits. Am J Physiol Heart Circ Physiol 279: H2350-H2359, 2000.
335. ATP channel elicits late preconditioning against myocardial infarction via protein kinase C signaling pathway. Circ Res 85: 1146-1153, 1999.
336. Tamura K, Tsuji H, Nishiue T, Tokunaga S, and Iwasaka T. Association of preceding angina with in-hospital life threating ventricular tacharrhythmias and late potentials in patients with a first acute myocardial infarction. Am Heart J 133: 297-301, 1997.
337. Tanaka M, Fujiwara H, Yamasaki K, Miyamae M, Yokota R, Hasegawa K, Fujiwara T, and Sasayama S. Ischemic preconditioning elevates cardiac stress protein but does not limit infarct size 24 or 48 h later in rabbits. Am J Physiol Heart Circ Physiol 267: H1476-H1482, 1994.
338. Tang X, Qiu Y, Park S, Sun J, Kalya A, and Bolli R. Time course of late preconditioning against myocardial stunning in conscious pigs. Circ Res 79: 423-434, 1996.
339. Tang X-L, Qiu Y, Turrens JF, Sun JZ, and Bolli R. Late preconditioning against stunning is not mediated by increased antioxidant defenses in conscious pigs. Am J Physiol Heart Circ Physiol 273: H1652-H1657, 2002.
340. Tanno M, Tsuchida A, Nozawa Y, Matsumoto T, Hasegawa T, Miura T, and Shimamoto K. Roles of tyrosine kinase and protein kinase C in infarct size limitation by repetitive ischemic preconditioning in the rat. J Cardiovasc Pharmacol 35: 345-352, 2000.
341. Teoh LKK, Grant R, Hulf JA, Pugsley WB, and Yellon DM. A comparison between ischemic preconditioning, intermittant cross-clamp fibrillation and cold crystalloid cardioplegia for myocardial protection during coronary artery bypass graft surgery. Cardiovasc Surgery 10: 251-255, 2002.
342. Teoh LKK, Grant R, Hulf JA, Pugslry WB, and Yellon DM. The effect of preconditioning (ischaemic and pharmacological) on myocardial necrosis following coronary artery bypass surgery. Cardiovasc Res 53: 175-180, 2002.
343. The Iona Study Group. Effect of nicorandil on coronary events in patients with stable angina: the impact of nicorandil in angina (IONA) randomised trial. Lancet 359: 1269-1275, 2002.
344. Thornton J, Striplin S, Liu GS, Swafford A, Stanley AWH, Van Winkle DM, and Downey JM. Inhibition of protein synthesis does not block myocardial protection afforded by preconditioning. Am J Physiol Heart Circ Physiol 259: H1822-H1825, 1990.
345. Tiefenbrunn AJ and Sobel BE. Timing of coronary recanalization. Circulation 85: 2311-2315, 1992.
346. Toller WG, Gross ER, Kersten JR, Pagel PS, Gross GJ, and Warltier DC. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology 92: 1731-1739, 2000.
347. Tomai F. Warm up phenomenon and preconditioning in clinical practice. Heart 87: 99-100, 2002.
348. Tomai F, Crea F, Chiariello L, and Gioffrè PA. Ischemic preconditioning in humans: models, mediators, and clinical relevance. Circulation 100: 559-563, 1999.
349. Tomai F, Crea F, Danesi A, Perino M, Gaspardone A, Ghini AS, Cascarona MT, Chiariello L, and Gioffre PA. Mechanisms of the warm-up phenomenon. Eur Heart J 17: 1022-1027, 1996.
350. + channel blocker. Circulation 90: 700-705, 1994.
351. 1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J 17: 846-853, 1996.
352. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini AS, De Paulis R, Chiariello L, and Gioffre PA. Phentolamine prevents adaptation to ischaemia during coronary angioplasty: role of alpha adrenergic receptors in ischemic preconditioning. Circulation 96: 2171-2177, 1997.
353. Tomai F, Crea F, Gaspardone A, Versaci F, Ghini C, Desideri G, Chiariello L, and Gioffre PA. Effects of naloxone on myocardial ischemic preconditioning in humans. J Am Coll Cardiol 33: 1863-1869, 1999.
354. Tomai F, Danesi A, Ghini AS, Crea F, Perino M, Gaspardone A, Ruggeri G, Chiarello L, and Gioffre PA. Effects of KATP channel blockade. Eur Heart J 20: 196-202, 1999.
355. Tomai F, Depaulis R, Pento De Pepo A, Colagrande L, Caprara E, Polisca P, Dematteis G, Ghini AS, Forlani S, Collela D, and Chiariello L. Beneficial impact of isoflurane during coronary artery bypass surgery on troponin I release. Int J Cardiol 9: 1007-1014, 1999.
356. Tong H, Chen W, Steenbergen C, and Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 87: 309-315, 2000.
357. Topol EJ. Acute myocardial infarction: thrombolysis. Heart 83: 122-126, 2000.
358. Tritto I, D'Andrea D, Eramo N, Scognamiglio A, De Simone C, Violante A, Esposito A, Chiariello M, and Ambrosio G. Oxygen radicals can induce preconditioning in rabbit hearts. Circ Res 80: 743-748, 1997.
359. 1-selective agonist is diminished after prolonged infusion as is the cardioprotective effect of ischaemic preconditioning in rabbit heart. J Mol Cell Cardiol 26: 303-311, 1994.
360. Turrens JF, Thornton J, Barnard ML, Snyder S, Liu G, and Downey JM. Protection from reperfusion injury by preconditioning hearts does not involve increased antioxidant defenses. Am J Physiol Heart Circ Physiol 262: H585-H589, 1992.
361. Tzivoni D and Maybaum S. Attenuation of severity of myocardial ischemia during repeated daily ischemic episodes. J Am Coll Cardiol 30: 119-124, 1997.
362. Vahlhaus C, Schulz R, Post H, Rose J, and Heusch G. Prevention of ischemic preconditioning only by combined inhibition of protein kinase C and protein tyrosine kinase in pigs. J Mol Cell Cardiol 30: 197-209, 1998.
363. Vanden Hoek TL, Becker Z-H, Shao C-Q, Li LB, and Schumacker PT. Preconditioning in cardiomyocytes protects by attenuating oxidant stress at reperfusion. Circ Res 86: 541-548, 2000.
364. Vanderheide R and Ganote C. Increased myocyte fragility following anoxic injury. J Mol Cell Cardiol 19: 1085-1103, 1987.
365. Vane JR, Bakhle YS, and Blotting RM. Cyclooxygnase 1 and 2. Annu Rev Pharmacol Toxicol 38: 97-120, 1998.
366. ATP channel. Am J Physiol Heart Circ Physiol 266: H829-H839, 1994.
367. Van Winkle DM, Thornton JD, Downey DM, and Downey JM. The natural history of preconditioning: cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coronary Artery Dis 2: 613-619, 1991.
368. Van Wylen DGL. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 89: 2283-2289, 1994.
369. Vegh A, Komori S, Szekeres L, and Parratt JR. Antiarrhythmic effects of preconditioning in anaesthetised dogs and rats. Cardiovasc Res 26: 487-495, 1992.
370. Vegh A, Papp JG, and Parratt JR. Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br J Pharmacol 113: 1081-1082, 1994.
371. Vegh A, Szekeres L, and Parratt JR. Protective effects of preconditioning of the ischaemic myocardium involve cyclo-oxygenase products. Cardiovasc Res 24: 1020-1023, 1990.
372. Verdouw PD, Gho BC, Koning MM, Schoemaker RG, and Duncker DJ. Cardioprotection by ischemic and nonischemic myocardial stress and ischemia in remote organs. Implications for the concept of ischemic preconditioning. Ann NY Acad Sci 793: 27-42, 1996.
373. Von Ruecker AA, Han-Jeon B-G, Wild M, and Bidlingmaier F. Protein kinase C involvement in lipid peroxidation and cell membrane damage induced by oxygen-based radicals in hepatocytes. Biochem Biophys Res Commun 163: 836-842, 1989.
374. Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Watcher MP, and Siekierka JJ. Rwj 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase. J Pharmacol Exp Ther 291: 680-687, 1999.
375. Walker DM, Marber MS, Walker JM, and Yellon DM. Preconditioning in isolated superfused rabbit papillary muscles. Am J Physiol Heart Circ Physiol 266: H1534-H1540, 1994.
376. Walsh RS, Daly JJ, Cohen MV, and Downey JM. Blockade of both adenosine and alpha-adrenergic receptors is required to prevent hypoxic preconditioning in rabbit hearts (Abstract). J Am Coll Cardiol 23: 396A, 1994.
377. ATP channels in diazoxide-mediated protection in isolated rabbit hearts. Am J Physiol Heart Circ Physiol 280: H246-H255, 2001.
378. 2+ overload injury via protein kinase C signaling pathway. J Mol Cell Cardiol 30: 2423-2435, 1998.
379. Wang Y, Huang S, Sah VP, Ross J Jr, Heller Brown J, Han J, and Chien KR. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 273: 2161-2168, 1998.
380. ATP channels by diazoxide. Circulation 104: 85-90, 2001.
381. Weinbrenner C, Liu G-S, Cohen MV, and Downey JM. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart. J Mol Cell Cardiol 29: 2383-2391, 1997.
382. Weinbrenner C, Liu G-S, Downey JM, and Cohen MV. Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia. Cardiovasc Res 38: 676-684, 1998.
383. Weselcouch EO, Baird AJ, Sleph P, and Grover GJ. Inhibition of nitric oxide synthesis does not affect ischemic preconditioning in isolated perfused rat hearts. Am J Physiol Heart Circ Physiol 268: H242-H249, 1995.
384. Weselcouch EO, Baird AJ, Sleph PG, Dzwonczyk S, Murray HN, and Grover GJ. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res 29: 126-132, 1995.
385. Whalen DA Jr, Hamilton DG, Ganote CE, and Jennings RB. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol 74: 381-398, 1974.
386. Williams DO, Bass TA, Gerwirtz H, and Most MA. Adaptation to the stress of tachycardia in patients with coronary artery disease: insight into the mechanism of the warm-up phenomenon. Circulation 71: 687-692, 1985.
387. Wilson S, Song W, Karoly K, Ravingerova T, Vegh A, Papp J, Tomisawa S, Parratt JR, and Pyne NJ. Delayed cardioprotection is associated with the sub-cellular relocalisation of ventricular protein kinase Cε, but not p42/44MAPK. Mol Cell Biochem 160/161: 225-230, 1996.
388. Woolfson RG, Patel VC, Neild GH, and Yellon DM. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. Circulation 91: 1545-1551, 1995.
389. Xi L, Jarrett NC, Hess ML, and Kukreja RC. Essential role of inducible nitric oxide synthase in monophosphoryl lipid A-induced late cardioprotection. Circulation 99: 2157-2163, 1999.
390. + exchanger is critical to reperfusion damage and preconditioning in the isolated rat heart. Cardiovasc Res 48: 244-253, 2000.
391. Xuan Y-T, Tang X-L, Banerjee S, Takano H, Li RC, Han H, Qiu Y, Li JJ, and Bolli R. Nuclear factor kappaB plays an essential role in the late phase of preconditioning in conscious rabbits. Circ Res 84: 1095, 1999.
392. Xuan Y-T, Tang X-L, Qiu Y, and Banerjee S. Biphasic response of cardiac NO synthase to ischaemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol 279: H2360-H2371, 2000.
393. 201TI myocardial SPECT. J Nucl Med 41: 830-836, 2000.
394. Yamashita N, Hoshida S, Nishida M, Igarashi J, Taniguchi N, Tada M, Kuzuya T, and Hori M. Heat shock-induced manganese superoxide dismutase enhances the tolerance of cardiac myocytes to hypoxia-reoxygenation injury. J Mol Cell Cardiol 29: 1805-1813, 1997.
395. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, and Hori M. Involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol 131: 415-422, 2000.
396. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T, and Hori M. Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 189: 1699-1706, 1999.
397. Yamashita N, Hoshida S, Otsu K, Taniguchi N, Kuzuya T, and Hori M. The involvement of cytokines in the second window of ischaemic preconditioning. Br J Pharmacol 131: 415-422, 2000.
398. Yamashita N, Hoshida S, Taniguchi N, Kuzuya T, and Hori M. A "second window of protection" occurs 24 h after ischemic preconditioning in the rat heart. J Mol Cell Cardiol 30: 1181-1189, 1998.
399. Yamashita N, Hoshida S, Taniguchi N, Kuzuya T, and Hori M. Whole-body hyperthermia provides biphasic cardioprotection against ischemia/reperfusion injury in the rat. Circulation 98: 1414-1421, 1998.
400. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, Kamada T, and Tada M. Induction of manganese super-oxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 94: 2193-2199, 1994.
401. Yang X-M, Baxter GF, Heads RJ, Yellon DM, Downey JM, and Cohen MV. Infarct limitation of the second window of protection in a conscious rabbit model. Cardiovasc Res 31: 777-783, 1996.
402. Yang X-M, Sato H, Downey JM, and Cohen MV. Protection of ischemic preconditioning is dependent upon a critical timing sequence of protein kinase C activation. J Mol Cell Cardiol 29: 991-999, 1997.
403. Yao Z, McPherson BC, Liu H, Shao Z, Li C, Qin Y, Vanden Hoek TL, Becker LB, and Schumacker PT. Signal transduction of flumazenil-induced preconditioning in myocytes. Am J Physiol Heart Circ Physiol 280: H1249-H1255, 2001.
404. Yao Z, Tong J, Tan X, Li C, Shao Z, Kim WC, Vanden Hoek TL, Becker LB, Head CA, and Schumacker PT. Role of reactive oxygen species in acetylcholine-induced preconditioning in cardiomyocytes. Am J Physiol Heart Circ Physiol 277: H2504-H2509, 1999.
405. Yaoita H, Ogawa K, Maehara K, and Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation 97: 276-281, 1998.
406. Yeghiazarians Y, Braunstein JB, Askari A, and Stone PH. Unstable angina pectoris. N Engl J Med 342: 101-114, 2000.
407. Yellon DM, Alkhulaifi AM, and Pugsley WB. Preconditioning the human myocardium. Lancet 342: 276-277, 1993.
408. Yellon DM and Baxter GF. A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J Mol Cell Cardiol 27: 1023-1034, 1995.
409. Yellon DM and Baxter GF. Reperfusion injury revisited: is there a role for growth factor signalling in limiting lethal reperfusion injury. Trends Cardiovasc Med 9: 245-248, 1999.
410. Yellon DM and Latchman DS. Stress proteins and myocardial protection. J Mol Cell Cardiol 24: 113-124, 1992.
411. Yin T, Sandhu G, Wolfgang CD, Burrier A, Webb RL, Rigel DF, Hai T, and Whelan J. Tissue-specific pattern of stress kinase activation in ischemic/reperfused heart and kidney. J Biol Chem 272: 19943-19950, 1997.
412. Ytrehus K, Liu Y, and Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol Heart Circ Physiol 266: H1145-H1152, 1994.
413. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, Yang X-M, Herbert D, Cohen MV, and Downey JM. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol Heart Circ Physiol 267: H2383-H2390, 1994.
414. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342: 145-153, 2000.
415. Zahn R, Schiele R, Schneider S, Gitt AK, Seidl K, Bossaller C, Schuler G, Gottwick M, Altmann E, Rosahl W, and Senges J. The myocardial Registry Study Group. Effects of preinfarction angina pectoris on outcome in patients with acute myocardial infarction treated with primary angioplasty (results from the myocardial infarction registry). Am J Cardiol 87: 1-6, 2001.
416. Zhao J, Renner O, Wightman L, Sugden PH, Stewart L, Miller AD, Latchman DS, and Marber MS. The expression of constitutively active isotopes of protein kinase C to investigate preconditioning. J Biol Chem 273: 23072-23079, 1998.
417. Zhao T, Xi L, Chelliah J, Levasseur JE, and Kukreja RC. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice. Circulation 102: 902-907, 2000.
418. Zhu L, Fukuda S, Cordis G, Das DK, and Maulik N. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriola endothelial cells by hypoxic preconditioning. FEBS Lett 508: 369-374, 2001.